Objective. The effects of doxycycline were tested in an in vitro system in which the cartilages of embryonic avian tibias are completely degraded.Methods. Tibias were cultured with 5, 20, or 40 pg/ml doxycycline. Control tibias were cultured without doxycycline. Conditioned media and tissue sections were examined for enzyme activity and matrix loss.Results. Cartilages were not resorbed in the presence of doxycycline, whereas control cartilages were completely degraded. Collagen degradation was reduced in association with treatment with doxycycline at all doses studied. Higher concentrations of doxycycline reduced collagenase and gelatinase activity and prevented proteoglycan loss, cell death, and deposition of type X collagen in the cartilage matrix; in addition, treatment with doxycycline at higher concentrations caused increases in the length of the hypertrophic region.Conclusion. The effects of doxycycline extend beyond inhibition of the proteolytic enzymes by stimulating cartilage growth and disrupting the terminal differentiation of chondrocytes.
Tetracyclines decreased collagenase activity in several animal as well as in the synovial tissues and fluid of seven patients with rheumatoid arthritis who had received minocycline prior to joint replacement. The effects of doxycycline were tested in an in vitro system in which the cartilage of embryonic avian tibias was degraded during culture in the absence of serum6,'; during culture, cartilage matrix loss occurs in two phases with proteoglycan loss preceding collagen loss. The phase of collagen loss is accompanied by the release of active collagenase and gelatinase into the conditioned media.To test the potential of doxycycline to inhibit degradation of cartilage during culture, tibias from 12-day chicken embryos were cultured for 30 days with 5, 20, or 40 kg/mL of doxycycline (Sigma). Control tibias were cultured under identical conditions but without doxycycline. Following the 30-day culture, conditioned media were examined to detect matrix metalloproteinase activity, collagenase, and gelatinase using gelatin zymograms.* The conditioned media were also analyzed for hydroxyproline content9 and sulfated glycosaminoglycan and lactate dehydrogenase activity (Sigma Diagnostic Kit-LD No. 34O-UV).l1 The tibias were processed for histologic observation after being fixed in 4% paraformaldehyde and embedded in paraffin. Sections were stained with safranin 0 and fast green to observe proteoglycan loss.'*In the presence of all three concentrations of doxycycline, cartilage was not resorbed, whereas control cartilage was completely degraded as previously described.6 In the gelatin zymograms, collagenase activity was identified by two bands at an M , of 57,000 and 50,000 on culture days 18-30 as previously described'; collagenase activity in the conditioned media of the doxycycline-treated tibias was not detectable on gelatin zymograms. Gelatinase is constitutively produced by the cultures and appears on the zymograms as 66,000 and 62,000 cleared bands. Gelatinase activity was present throughout the culture in the presence of 5 kg/mL of doxycycline. At both 20 and 40 pg/mL of doxycycline, gelatinase was undetectable by culture day 18. Collagen degradation, evaluated as hydroxyproline content in the conditioned media, was reduced at all doses of doxycycline, whereas proteoglycan degradation was inhibited in a dose-dependent manner. Lactate dehydrogenase in the conditioned media of the control cultures showed peak activity (18,000 units/ tibia) on culture day 10 and returned to baseline (400 unitdtibia) by culture day 14. Doxycycline reduced peak lactate dehydrogenase activity in a dose-dependent fashion. At higher concentrations of doxycycline the cartilage length was increased
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.